Supplementary Figure S4 from Tarloxotinib Is a Hypoxia-Activated Pan-HER Kinase Inhibitor Active Against a Broad Range of HER-Family Oncogenes
| Autor: | Robert C. Doebele, Stephen V. Liu, Chul Kim, Adam V. Patterson, Jeff B. Smaill, Matthew R. Bull, Shevan Silva, Vijaya G. Tirunagaru, Andrea E. Doak, Anh T. Le, Adriana Estrada-Bernal |
|---|---|
| Rok vydání: | 2023 |
| Popis: | Tarloxotinib (prodrug) is less effective against WT and mutant forms of EGFR and HER2. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|